dicentra, a leading consultant specializing in regulatory strategies for North American health products, advised CCMP Capital Advisors LLC on its acquisition of Jamieson Laboratories Ltd., Canada’s leading provider of vitamins, minerals and nutrition supplements.
dicentra conducted a thorough due diligence investigation into Jamieson’s two manufacturing facilities and the quality of hundreds of its products. In addition, dicentra audited Jamieson’s compliance to health regulations in the 50 countries to which it distributes.
“We are proud to have played a part in the acquisition of Jamieson by CCMP,” said Alicja Wojewnik, president and CEO of dicentra. “Jamieson is one of Canada’s oldest and most respected companies, and we are confident that it will continue its long history of excellence.”
Peter Wojewnik, vice president of business development at dicentra, added, “As part of our work, the talented team here at dicentra took a deep dive into Jamieson’s compliance on the regulatory front. In the end, we were impressed by Jamieson’s high level of commitment to producing the highest quality products.”
Established in 1922, Jamieson Laboratories is Canada’s largest manufacturer and distributor of advanced natural-health products and a world-leading innovator in the development of proprietary supplement formulas. Jamieson products are made at the Company’s state-of-the-art laboratories in Windsor, Ontario. With corporate offices in Toronto, Jamieson exports products to more than 50 countries.
CCMP specializes in buyout and growth equity investments in North America and Europe. The firm’s core investment strategy is the operational transformation of businesses in partnership with management. With investment professionals in New York, Houston and London, the firm specializes in four industry sectors: consumer, energy, industrial and health care.